Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NextCure Inc.

    NASDAQ: NXTC · Real-Time Price · USD
    0.50
    0.03 (5.69%)
    At close: Jun 05, 2025, 3:59 PM
    0.50
    -0.02%
    After-hours: Jun 05, 2025, 06:15 PM EDT

    NextCure Statistics

    Share Statistics

    NextCure has 28.05M shares outstanding. The number of shares has increased by 0.12% in one year.

    Shares Outstanding

    n/a
    		 28.05M

    Shares Change (YoY)

    n/a
    		 0.12%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 57.32%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 300

    FTD / Avg. Volume

    n/a
    		 0.18%

    Short Selling Information

    The latest short interest is 317.03K, so 1.13% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 317.03K

    Short % of Shares Out

    n/a
    		 1.13%

    Short % of Float

    n/a
    		 1.15%

    Short Ratio (days to cover)

    n/a
    		 2.29

    Valuation Ratios

    The PE ratio is -0.39 and the forward PE ratio is -0.33. NextCure's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -0.39

    Forward PE

    n/a
    		 -0.33

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 0.33

    P/FCF Ratio

    n/a
    		 -0.52

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for NextCure.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.5, with a Debt / Equity ratio of 0.09.

    Current Ratio

    n/a
    		 7.5

    Quick Ratio

    n/a
    		 7.5

    Debt / Equity

    n/a
    		 0.09

    Debt / EBITDA

    n/a
    		 -0.11

    Debt / FCF

    n/a
    		 -0.14

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,294,279.07

    Employee Count

    n/a
    		 43

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -64.49% in the last 52 weeks. The beta is 1.08, so NextCure's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.08

    52-Week Price Change

    n/a
    		 -64.49%

    50-Day Moving Average

    n/a
    		 0.43

    200-Day Moving Average

    n/a
    		 0.94

    Relative Strength Index (RSI)

    n/a
    		 51.38

    Average Volume (20 Days)

    n/a
    		 168,328

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -59.75M

    Net Income

    n/a
    		 -55.65M

    EBITDA

    n/a
    		 -52.79M

    EBIT

    n/a
    		 -57.21M

    Earnings Per Share (EPS)

    n/a
    		 -1.99
    Full Income Statement

    Balance Sheet

    The company has 27.73M in cash and 5.95M in debt, giving a net cash position of 21.78M.

    Cash & Cash Equivalents

    n/a
    		 27.73M

    Total Debt

    n/a
    		 5.95M

    Net Cash

    n/a
    		 21.78M

    Retained Earnings

    n/a
    		 -380.14M

    Total Assets

    n/a
    		 67.14M

    Working Capital

    n/a
    		 53.16M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -40.8M and capital expenditures -474K, giving a free cash flow of -41.28M.

    Operating Cash Flow

    n/a
    		 -40.8M

    Capital Expenditures

    n/a
    		 -474K

    Free Cash Flow

    n/a
    		 -41.28M

    FCF Per Share

    n/a
    		 -1.48
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    NXTC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NXTC is $3.5, which is 614.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $3.5

    Price Target Difference

    n/a
    		 614.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -9.05

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist